BioCentury
ARTICLE | Company News

Cubist, Optimer deal

October 28, 2013 7:00 AM UTC

Cubist completed the acquisition of Optimer in a deal valued at up to $801 million. Optimer received about $551 million up front in cash and a tradable contingent value right (CVR) for a one-time paym...